5437-98-9COc1ccc(NC(=O)CC(C)=O)cc1SWAJJKROCOJICG-UHFFFAOYSA-N5437-98-9DTXSID7044689CHEMBL3185475안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
This chemical does not meet GHS hazard criteria for 80.6% (104 of 129) of all reports.
Warning
H302 (18.6%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 129 reports by companies from 5 notifications to the ECHA C&L Inventory.
Chemical: Butanamide, N-(4-methoxyphenyl)-3-oxo-
REACH registered substance: 4'-methoxyacetoacetanilide (EC: 226-615-6)
용도N-(4-Methoxyphenyl)-3-oxobutanamide is an intermediate in the synthesis of Tafenoquine-d3 Succinate is the labelled analog of Tatenoquine (T004760), a new 8-aminoquinoline with an improved therapeutic index and safety profile as compared to primaquine (P733500).Tafenoquine has the potential to become a widely used drug in the prevention and treatment of malaria infection and could replace some currently used drugs as resistant strains of Plasmodium species increase.
현재 필터 조건에 해당하는 반응 기록이 없습니다.
불러오는 중…
WHITE TO VERY SLIGHTLY YELLOW POWDER